Lv0
0 积分 2024-04-08 加入
B cell-targeted therapies in systemic lupus erythematosus: Current status and perspectives
11天前
已完结
Advances in the management of systemic lupus erythematosus
11天前
已完结
The history of lupus throughout the ages
11天前
已完结
Single‐cell RNA sequencing informs precision targeting of monogenic lupus associated with IKZF1 haploinsufficiency
1个月前
已完结
Molecular mechanism and role of miRNA-155 ribonucleic acid in podocyte apoptosis in lupus nephritis: SOCS1 protein expression regulates JAK/STAT pathway transduction
1个月前
已完结
Sirt4 deficiency promotes the development of atherosclerosis by activating the NF-κB/IκB/CXCL2/3 pathway
1个月前
已完结
Ruxolitinib, a novel JAK/STAT-targeted therapy through restoring mucosal homeostasis for chronic rhinosinusitis with nasal polyps
1个月前
已完结
Unraveling the safety profile of GLP-1 receptor agonists: Mechanistic insights with a focus on semaglutide
1个月前
已完结
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
2个月前
已完结
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
2个月前
已完结
皖公网安备34019202002308
